Andrea Calcagno
机构: Unit of Infectious Diseases, Department of Medical Sciences, University of Torino
每年引用次数
引用次数
引用: 5,344
H-指数: 35
I10-指数 : 151
出版物: 444
New UPLC-MS/MS method for simultaneous determination of dolutegravir, elvitegravir, rilpivirine and other 14 HIV drugs in human plasma
S. Bonora , A. D'Avolio , A. Ariaudo , M. Simiele
VI Congresso Nazionale ICAR
2014
[Clinico-microbiological investigation in septic complications after gastrointestinal surgery. A multicenter study].
F. Cafiero , A. Gramegna , B. Ardau , M. Battezzati
Minerva Chirurgica 41 965 -970
1986
Tenofovir Coadministration Is Not Associated With Lower Plasma Exposure in the Clinical Setting: Erratum
S. Bonora , A. Calcagno , M. C. Tettoni
Journal of Acquired Immune Deficiency Syndromes 53 ( 1)
2010
Pharmacokinetic of doxorubicin during chemotherapy in HIV patients affected by Hodgkin disease and Non- Hodgkin’s Lymphoma: the PKCT study
S. Bonora , A. D'Avolio , A. Galli , A. Calcagno
VI Congresso Nazionale ICAR
2014
High Incidence of Cytomegalovirus Reactivation in HIV-positive Patients Treated for Haematological Malignancies
R. Balbiano , F. Lipani , S. Bonora , R. Bertucci
Italian Conference on AIDS and retroviruses 36 43 -44
2013
Determinants of Renal Tubular Dysfunction in HIV-positive Patients of More than 50 Years-old
J. Cusato , S. Bonora , A. D’Avolio , M. Simiele
VI Congresso Nazionale ICAR
2014
Pharmacokinetic of caspofungin in patients with invasive candidiasis
L. Baietto , A. D'Avolio , N. Pagani , S. Corcione
25th European Congress of Clinical Microbiology and Infectious Diseases
2015
Single Nucleotide Polymorphisms of ABCB1 Gene Influence Daptomycin Pharmacokinetics in Adult Patients. [A-1769]
L. Baietto , J. Cusato , A. D’Avolio , C. Montrucchio
52nd ICAAC 172 -172
2012
GREATER IMMUNOLOGICAL RECOVERY ASSOCIATED WITH ADDITIONAL ENFUVIRTIDE IN THE TREATMENT OF NAIVE HIV-INFECTED PATIENTS AT VERY ADVANCED DISEASE STAGES: 24-WEEK RESULTS OF A RANDOMIZED, CONTROLLED, PILOT STUDY
A. Sinicco , S. Bonora , A. D'Avolio , S. Fontana
Infection 37 41 -41
2009
2002 SLC28A2 65C>T PREDICT SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH HEPATITIS C TREATED WITH INTERFERON AND RIBAVIRIN, CONSIDERING ALL HCV GENOTYPE AND GENOTYPE 1/4
A. Smedile , F.G. De Rosa , S. Bonora , M. Rizzetto
Journal of Hepatology 52
8
2010
HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing.
T. Ruggiero , E. Burdino , A. Calcagno , S. Bonora
Infection 44 ( 6) 789 -792
3
2016
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)
S. Bonora , S. Rusconi , A. Calcagno , M. Bracchi
Journal of Antimicrobial Chemotherapy 70 ( 11) 3096 -3099
13
2015
Therapeutic drug monitoring of boosted PIs in HIV-positive patients: undetectable plasma concentrations and risk of virological failure
A. Calcagno , N. Pagani , A. Ariaudo , G. Arduino
Journal of Antimicrobial Chemotherapy 72 ( 6) 1741 -1744
9
2017
Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?
A. Calcagno , M. Fiumanò , D. Zugna , J. Cusato
Pharmacogenomics Journal 19 ( 1) 65 -71
1
2019
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation
C. Montrucchio , A. De Nicolò , G. D'Ettorre , F. D'Ascenzo
International Journal of Antimicrobial Agents 55 ( 4) 105908 -105908
6
2020
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
G. Guaraldi , A. Malagoli , A. Calcagno , C. Mussi
BMC Geriatrics 18 ( 1) 99 -109
127
2018
Clinically Significant Drug Interaction between Tipranavir-Ritonavir and Phenobarbital in an HIV-Infected Subject
S. Bonora , A. Calcagno , S. Fontana , A. D'Avolio
Clinical Infectious Diseases 45 ( 12) 1654 -1655
9
2007
Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus
D. Aguilar Marucco , L. Veronese , D. Gonzalez de Requena , S. Bonora
Journal of Antimicrobial Chemotherapy 59 ( 3) 565 -568
13
2007
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients
D. G. de Requena , S. Bonora , A. Castagna , H. Hasson
Journal of Antimicrobial Chemotherapy 62 ( 2) 384 -387
7
2008
Prevalence and predictors of blood-brain barrier damage in the HAART era
A. Calcagno , M. C. Alberione , A. Romito , D. Imperiale
Journal of NeuroVirology 20 ( 5) 521 -525
13
2014